Search - tctmd.com

Displaying 21 - 40 of 310

Sort: Relevancy | Date

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

May 15, 2024

Debate Continues on TAVI Choice for Women With Small Annuli

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

April 07, 2024

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

Top Structural Heart News of 2023

News Daily News

Top Structural Heart News of 2023

January 02, 2024

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

November 27, 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

November 03, 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

October 27, 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

October 2023 News Roundup

News Opinion CV Team Dispatch

October 2023 News Roundup

October 01, 2023

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

News Daily News

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

July 21, 2023

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

News Daily News

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

July 13, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.